Luliconazole Cream 1%
Sponsors
Bausch & Lomb Incorporated, Bausch Health Americas, Inc., PAEC General Hospital, Islamabad
Conditions
Pityriasis VersicolorTinea CorporisTinea CrurisTinea Pedis
Phase 4
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
CompletedNCT02394340
Start: 2015-02-03End: 2015-04-01Updated: 2019-11-27
Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris
CompletedNCT02767271
Start: 2015-12-02End: 2016-04-27Updated: 2019-11-27
Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis
CompletedNCT02767947
Start: 2016-02-08End: 2016-09-22Updated: 2019-11-27
Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.
Not yet recruitingNCT07333170
Start: 2026-02-28End: 2026-11-30Target: 86Updated: 2026-01-12